Foresite Capital Opportunity Fund V, L.P.

Related Filers (12)

Ownership (17)

4
Thursday, 8/31/2023
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/19/2023
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/10/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/6/2023
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/22/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2023
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 6/13/2022
Theseus Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4/A
Friday, 6/10/2022
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4/A
Thursday, 12/30/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/28/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/23/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/25/2021
FS Development Corp. II: Initial statement of beneficial ownership of securities
4
Tuesday, 2/9/2021
Gemini Therapeutics, Inc. /DE: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/9/2020
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/4/2020
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/3/2020
Kinnate Biopharma Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 10/27/2020
FS Development Corp.: Initial statement of beneficial ownership of securities
Show More